Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 13 to 17, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 13 to 17, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots
FRIDAY, Sept. 17, 2021 (HealthDay News) — U.S. Food and Drug Administration advisors are meeting today to consider whether it is safe and effective for Americans to receive a third “booster” dose of the Pfizer-BioNTech COVID-19 vaccine.
COVID-19 Vaccine Booster Dose Cuts Infection in Those 60 and Older
FRIDAY, Sept. 17, 2021 (HealthDay News) — Among Israeli adults aged 60 years and older, those receiving a third booster dose of the Pfizer-BioNTech COVID-19 vaccine have rates of confirmed COVID-19 and severe illness that are substantially lower than the rates seen for individuals only receiving the two original vaccine doses, according to a study published online Sept. 15 in the New England Journal of Medicine.
MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
FRIDAY, Sept. 17, 2021 (HealthDay News) — Patients with multiple sclerosis receiving anti-CD20 monoclonal antibody treatment can mount T-cell responses to mRNA COVID-19 vaccines, according to a study published online Sept. 14 in Nature Medicine.
Government Buys More Monoclonal Antibody Treatments to Ward Off Shortage
THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers.
NIH Spending Nearly $470 Million on ‘Long-Haul COVID’ Study
THURSDAY, Sept. 16, 2021 (HealthDay News) — The U.S. National Institutes of Health is spending nearly $470 million to study the long-term effects of COVID-19, the agency announced Wednesday.
Hospitalizing the Unvaccinated Has Cost U.S. Nearly $6 Billion
THURSDAY, Sept. 16, 2021 (HealthDay News) — The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported.
Pandemic Caused Many Women to Abandon Plans for More Children
THURSDAY, Sept. 16, 2021 (HealthDay News) — Nearly half of mothers report they halted plans to have additional children because of the COVID-19 pandemic, according to a study published online Sept. 15 in JAMA Network Open.
COVID-19 Vaccines Prevent Hospitalizations in High-Risk Populations
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
.jpeg)
